405 POSTER Final results of a Phase I/II study of CTCE-9908, a novel anticancer agent that inhibits CXCR4, in patients with advanced solid cancers
S.J. Hotte, H.W. Hirte, P. Moretto, A. Iacobucci, D. Wong, W. Korz, W.H. MillerVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72339-5
File:
PDF, 64 KB
english, 2008